312 related articles for article (PubMed ID: 34709369)
21. Low-dose computed tomography screening for lung cancer and pleural mesothelioma in an asbestos-exposed population: baseline results of a prospective, nonrandomized feasibility trial--an Alpe-adria Thoracic Oncology Multidisciplinary Group Study (ATOM 002).
Fasola G; Belvedere O; Aita M; Zanin T; Follador A; Cassetti P; Meduri S; De Pangher V; Pignata G; Rosolen V; Barbone F; Grossi F
Oncologist; 2007 Oct; 12(10):1215-24. PubMed ID: 17962615
[TBL] [Abstract][Full Text] [Related]
22. Chest radiography or chest CT plus head and neck CT versus
Kim Y; Roh JL; Kim JS; Lee JH; Choi SH; Nam SY; Kim SY
Oral Oncol; 2019 Jan; 88():109-114. PubMed ID: 30616780
[TBL] [Abstract][Full Text] [Related]
23. Survival Following Detection of Stage I Lung Cancer by Screening in the National Lung Screening Trial.
Gierada DS; Pinsky PF
Chest; 2021 Feb; 159(2):862-869. PubMed ID: 32822676
[TBL] [Abstract][Full Text] [Related]
24. Incidental renal tumours on low-dose CT lung cancer screening exams.
Pinsky PF; Dunn B; Gierada D; Nath PH; Munden R; Berland L; Kramer BS
J Med Screen; 2017 Jun; 24(2):104-109. PubMed ID: 28482765
[TBL] [Abstract][Full Text] [Related]
25. Reduced lung-cancer mortality with low-dose computed tomographic screening.
; Aberle DR; Adams AM; Berg CD; Black WC; Clapp JD; Fagerstrom RM; Gareen IF; Gatsonis C; Marcus PM; Sicks JD
N Engl J Med; 2011 Aug; 365(5):395-409. PubMed ID: 21714641
[TBL] [Abstract][Full Text] [Related]
26. Reduced Lung-Cancer Mortality with Volume CT Screening in a Randomized Trial.
de Koning HJ; van der Aalst CM; de Jong PA; Scholten ET; Nackaerts K; Heuvelmans MA; Lammers JJ; Weenink C; Yousaf-Khan U; Horeweg N; van 't Westeinde S; Prokop M; Mali WP; Mohamed Hoesein FAA; van Ooijen PMA; Aerts JGJV; den Bakker MA; Thunnissen E; Verschakelen J; Vliegenthart R; Walter JE; Ten Haaf K; Groen HJM; Oudkerk M
N Engl J Med; 2020 Feb; 382(6):503-513. PubMed ID: 31995683
[TBL] [Abstract][Full Text] [Related]
27. Low-dose CT screening among never-smokers with or without a family history of lung cancer in Taiwan: a prospective cohort study.
Chang GC; Chiu CH; Yu CJ; Chang YC; Chang YH; Hsu KH; Wu YC; Chen CY; Hsu HH; Wu MT; Yang CT; Chong IW; Lin YC; Hsia TC; Lin MC; Su WC; Lin CB; Lee KY; Wei YF; Lan GY; Chan WP; Wang KL; Wu MH; Tsai HH; Chian CF; Lai RS; Shih JY; Wang CL; Hsu JS; Chen KC; Chen CK; Hsia JY; Peng CK; Tang EK; Hsu CL; Chou TY; Shen WC; Tsai YH; Tsai CM; Chen YM; Lee YC; Chen HY; Yu SL; Chen CJ; Wan YL; Hsiung CA; Yang PC;
Lancet Respir Med; 2024 Feb; 12(2):141-152. PubMed ID: 38042167
[TBL] [Abstract][Full Text] [Related]
28. Lung cancer screening in cigarette smokers in the province of Varese, Italy.
Dominioni L; Imperatori A; Rovera F; Ochetti A; Paolucci M; Dionigi G
Cancer; 2000 Dec; 89(11 Suppl):2345-8. PubMed ID: 11147609
[TBL] [Abstract][Full Text] [Related]
29. Lung Cancer Incidence and Mortality with Extended Follow-up in the National Lung Screening Trial.
National Lung Screening Trial Research Team
J Thorac Oncol; 2019 Oct; 14(10):1732-1742. PubMed ID: 31260833
[TBL] [Abstract][Full Text] [Related]
30. Occurrence and lung cancer probability of new solid nodules at incidence screening with low-dose CT: analysis of data from the randomised, controlled NELSON trial.
Walter JE; Heuvelmans MA; de Jong PA; Vliegenthart R; van Ooijen PMA; Peters RB; Ten Haaf K; Yousaf-Khan U; van der Aalst CM; de Bock GH; Mali W; Groen HJM; de Koning HJ; Oudkerk M
Lancet Oncol; 2016 Jul; 17(7):907-916. PubMed ID: 27283862
[TBL] [Abstract][Full Text] [Related]
31. Cigarette smoking prior to first cancer and risk of second smoking-associated cancers among survivors of bladder, kidney, head and neck, and stage I lung cancers.
Shiels MS; Gibson T; Sampson J; Albanes D; Andreotti G; Beane Freeman L; Berrington de Gonzalez A; Caporaso N; Curtis RE; Elena J; Freedman ND; Robien K; Black A; Morton LM
J Clin Oncol; 2014 Dec; 32(35):3989-95. PubMed ID: 25385740
[TBL] [Abstract][Full Text] [Related]
32. Lung cancer risk by years since quitting in 30+ pack year smokers.
Pinsky PF; Zhu CS; Kramer BS
J Med Screen; 2015 Sep; 22(3):151-7. PubMed ID: 25926339
[TBL] [Abstract][Full Text] [Related]
33. Assessment of Lung Cancer Risk Among Smokers for Whom Annual Screening Is Not Recommended.
Faselis C; Nations JA; Morgan CJ; Antevil J; Roseman JM; Zhang S; Fonarow GC; Sheriff HM; Trachiotis GD; Allman RM; Deedwania P; Zeng-Trietler Q; Taub DD; Ahmed AA; Howard G; Ahmed A
JAMA Oncol; 2022 Oct; 8(10):1428-1437. PubMed ID: 35900734
[TBL] [Abstract][Full Text] [Related]
34. Role of screening chest computed tomography in patients with advanced head and neck cancer.
Tan L; Greener CC; Seikaly H; Rassekh CH; Calhoun KH
Otolaryngol Head Neck Surg; 1999 May; 120(5):689-92. PubMed ID: 10229594
[TBL] [Abstract][Full Text] [Related]
35. Second Primary Lung Cancer Among Lung Cancer Survivors Who Never Smoked.
Choi E; Su CC; Wu JT; Aredo JV; Neal JW; Leung AN; Backhus LM; Lui NS; Le Marchand L; Stram DO; Liang SY; Cheng I; Wakelee HA; Han SS
JAMA Netw Open; 2023 Nov; 6(11):e2343278. PubMed ID: 37966839
[TBL] [Abstract][Full Text] [Related]
36. FDG-PET and detection of distant metastases and simultaneous tumors in head and neck squamous cell carcinoma: a comparison with chest radiography and chest CT.
Krabbe CA; Pruim J; van der Laan BF; Rödiger LA; Roodenburg JL
Oral Oncol; 2009 Mar; 45(3):234-40. PubMed ID: 18715818
[TBL] [Abstract][Full Text] [Related]
37. Factors Associated With Nonadherence to Lung Cancer Screening Across Multiple Screening Time Points.
Lin Y; Liang LJ; Ding R; Prosper AE; Aberle DR; Hsu W
JAMA Netw Open; 2023 May; 6(5):e2315250. PubMed ID: 37227725
[TBL] [Abstract][Full Text] [Related]
38. Evaluation of the Benefits and Harms of Lung Cancer Screening With Low-Dose Computed Tomography: Modeling Study for the US Preventive Services Task Force.
Meza R; Jeon J; Toumazis I; Ten Haaf K; Cao P; Bastani M; Han SS; Blom EF; Jonas DE; Feuer EJ; Plevritis SK; de Koning HJ; Kong CY
JAMA; 2021 Mar; 325(10):988-997. PubMed ID: 33687469
[TBL] [Abstract][Full Text] [Related]
39. Detection of lung cancer through low-dose CT screening (NELSON): a prespecified analysis of screening test performance and interval cancers.
Horeweg N; Scholten ET; de Jong PA; van der Aalst CM; Weenink C; Lammers JW; Nackaerts K; Vliegenthart R; ten Haaf K; Yousaf-Khan UA; Heuvelmans MA; Thunnissen E; Oudkerk M; Mali W; de Koning HJ
Lancet Oncol; 2014 Nov; 15(12):1342-50. PubMed ID: 25282284
[TBL] [Abstract][Full Text] [Related]
40. Radiation risks in lung cancer screening programs: a comparison with nuclear industry workers and atomic bomb survivors.
McCunney RJ; Li J
Chest; 2014 Mar; 145(3):618-24. PubMed ID: 24590022
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]